Disclosure of interest: The authors of this study have nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P403 - ESOC25-2347 POST-STROKE EPILEPSY IN THE ERA OF ADVANCED REPERFUSION THERAPIES Catarina Guedes Vaz 1 , Alexandre Dias 2,3 , Ricardo Varela 1 , Isabel Silva 3 , Ana Moutinho 2,3 , Pedro Castro 4 , Bruno Castro 4 , Carla Oliveira 2,5 , Henrik Zetterberg 6 , Johan Gobom 6 , Manuel Correia 1,3 , Rui Magalhes 3 , Lus Maia 1,2,3 1 Servio de Neurologia, Centro Hospitalar Universitrio de Santo Antnio, ULSdSA, Porto, Portugal, 2 Instituto de Investigao e Inovao em Sade (i3S), Universidade do Porto, Porto, Portugal, 3 Instituto de Cincias Biomdicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal, 4 Servio de Neurologia, Centro Hospitalar Universitrio de So Joo, ULSdSJ, Porto, Portugal, 5 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal, 6 Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg (UGOT), Gothenburg, Sweden Background and Aims: Post-stroke epilepsy (PSE) is a significant comorbidity in stroke survivors
The cells were sub-cultured every 46 days using trypsin solution (0.5 w/v% trypsin5.3 mmol/L EDTA4Na solution without phenol red (10), Fujifilm Wako Pure Chemical Corporation)
The goal is simply to encourage mixingnot to create vigorous agitation
Read More2 comments
Guo C, Cong P, He Z, et al
